Aims Hcn4, which encodes the hyperpolarization-activated, cyclic nucleotide-sensitive channel (I h ), is a well-established marker of the cardiac sino-atrial node. We aimed to identify cis-elements in the genomic locus of the Hcn4 gene that regulate the transcription of Hcn4.
Introduction
The appropriate timing of cardiac muscle contraction is regulated by the electrical conduction system of the heart and consists of cardiomyocytes possessing specialized electrical function. The precise expression pattern of cardiac ion channel genes in relation to such electrophysiological properties has been extensively studied. 1, 2 Previous reports have demonstrated that the hyperpolarizationactivated, cyclic nucleotide-sensitive cation current (I h ) encoded by the Hcn4 gene appears one of the ion currents underlying pacemaker depolarization. 3, 4 In mammalian adult heart, Hcn4 is specifically expressed in the sino-atrial node (SAN). During development Hcn4 is also expressed in the foetal and neonatal chamber myocardium. As a result of this distribution, Hcn4 is now recognized as a key marker gene of the SAN. 5, 6 Despite its role as an SAN marker, little is known about the cis-elements that directly regulate Hcn4 expression. Progress in the genome project and comparative genomic-base approaches have proven useful in the identification of gene regulatory sequences in a wide range of genomic loci. 7, 8 We have previously reported that an 847 bp proximal sequence induces minimal promoter activity of the Hcn4 gene. 9 In addition to this proximal upstream region, we also identified conserved, non-coding sequences within the Hcn4 gene locus and analysed their enhancer function. We found that the novel enhancer contained binding sites for activator protein-1 (AP1) and myocyte enhancer factor-2 (MEF2) and played a critical role in the expression of Hcn4. These results outline the potential mechanisms underlying SAN differentiation.
Methods

Construction of the promoter reporter plasmid
Luciferase reporter constructs were prepared using pGL4.10 vector (Promega) and the Hcn4 promoter construct was obtained as previously described. 9 Conserved non-coding sequence (CNS) fragments were isolated from mouse genomic DNA by PCR with the primer pairs listed in Supplementary material online, Table S1 and were subcloned into the upstream region of the Hcn4 promoter.
Cell culture
For the culture of neonatal cardiomyocytes, 1-to 2-day-old rats were decapitated, the ventricle rapidly dissected and myocytes isolated by collagenase digestion (Worthington, type 2, 80 U/mL). The myocytes were then enriched by discontinuous Percoll gradient centrifugation (yield more than 90%).
For the culture of embryonic cardiomyocytes, rat embryos (13 days after fertilization) were removed from pregnant rats under deep anaesthesia with ether, the inflow tract of embryonic heart dissected and the primordial right and left appendixes removed. Myocytes were then isolated using the same procedure as that for the culture of neonatal myocytes.
Embryonic and neonatal cardiomyocytes were plated at a density of 2 Â 10 4 and 10 5 cells/well, respectively, in 24-well plates and cultured in DMEM with 10% foetal bovine serum. 9 All experiments were approved in advance by the animal Ethics Committee of Jichi Medical University. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Luciferase reporter gene assay
Luciferase reporter constructs (0.5 mg) and pGL4.74 vector (0.03 mg) were co-transfected into neonatal cardiomyocytes using Lipofectamine LTX (Invitrogen). Luciferase activities were measured 3 days after the transfection using the Dual-Luciferase Reporter Assay System (Promega). Transcriptional activities were obtained from three separate assays performed in quadruplicate.
Electrophoretic mobility shift assays
The myc-tagged mouse c-Jun/AP1 and MEF2C proteins were in vitro translated using TNT Quick Coupled Transcription/Translation System (Promega) and CNS13 DNA probes radiolabelled with [ 32 P]. The binding reaction was then performed in a reaction buffer (final volume¼20 mL) containing 20 mM HEPES (pH 7.6), 50 mM KCl, 1 mM MgCl 2 , 0.1% Nonidet P-40, 5% glycerol, 5 mM dithiothreitol, 1 mM EDTA, and 1 mg poly(dI-dC). The probe (10 fmol) incubated with 1 mL of protein was analysed on 4% polyacrylamide gels in Â0.25 TBE buffer. In competition experiments, 100-fold molar excess of double-strand oligonucleotides (AP1: 5 0 -ATT CTG AGT CAG AGA-3 0 and MEF2: 5 0 -AGG TGG GTT AAA AAT AGA GCC CT-3 0 ) were added.
Chromatin immunoprecipitation
Chromatin isolated from neonatal rat cardiomyocytes was immunoprecipitated with specific antibodies directed against anti-c-Jun/ AP1 (Calbiochem) and anti-MEF2 (AnaSpec) using the EZ chromatin immunoprecipitation (ChIP) assay kit (Upstate) and analysed by PCR using the following primer pairs: CNS13 ChIP primers 5 0 -CCT TGG TTG TGA GTC TGT GTC T-3 0 (forward) and 5 0 -AGT GGA GAG ACT GCT CTT TTC C-3 0 (reverse) and control ChIP primers 5 0 -AAT GGG ACT CCT CTT ACT CAT TTC T-3 0 (forward) and 5 0 -AAA GTC CCT GAT GAC ACA CTA GTT C-3 0 (reverse).
AAV vector production and transfection
Adeno-associated virus (AAV) vector plasmids contain an expression cassette consisting of a CMV promoter followed by the first intron of human growth hormone, target cDNA, woodchuck hepatitis virus post-transcriptional regulatory element (GenBank accession no. J04514) and the SV40 poly-A signal sequence, between the inverted terminal repeats of the AAV-3 genome. The plasmids pAAV-dnMEF2 and pAAV-GFP contained the cDNA of the dominant negative MEF2 (dnMEF2) fused with Orange fluorescent protein (Clontech) and GFP, respectively. The two helper plasmids, pHelper (Agilent) and pAAV1-RC, harbour the E2A, E4, and VA RNA genes of the adenovirus genome, and the AAV-1 rep and cap genes, respectively. HEK293 cells were cotransfected using the calcium phosphate coprecipitation method with the vector plasmid, pAAV1-RC and pHelper. AAV1 vectors were harvested and purified via two sequential continuous iodoxale ultracentrifugations. 
RT-PCR and Q-PCR analysis
Three days after the transfection of AAV1, total RNA was isolated from primary cultured embryonic myocytes using TRIZOL reagent (Invitrogen). Single-strand cDNA was synthesized using Superscript III (Invitrogen). Q-PCR was carried out with predesigned Taqman Probes for hcn4, hcn2, hcn1, stars, and the 18s rRNA, in an ABI Prism 7700 System (Applied Biosystems).
Immunostaining of cardiomyocytes
Cardiomyocytes were fixed with 4% paraformaldehyde and incubated with primary antibodies directed against HCN4 (1:200 dilution; Chemicon) and actinin (1:750; Monoclonal, Sigma). Following extensive washes, cells were incubated with Alexa Fluor 488-conjugated anti-rabbit or anti-mouse Ig secondary antibodies at a concentration of 1:500 (Molecular Probes).
Electrophysiological analysis
Electrophysiological measurements were carried out using an Axopatch200B amplifier and a Digidata 1320 interface (Axon). The bathing solution contained 140 mM NaCl, 5.4 mM KCl, 0.33 mM NaH 2 PO 4 , 0.5 mM MgCl 2 , 1.8 mM CaCl 2 , 0.5 mM BaCl 2 , 5 mM HEPES (pH 7.4 with NaOH), and the standard high K þ pipette solution contained 110 Aspartic acid, 30 mM KCl, 5 mM MgATP, 5 mM Na 2 creatine phosphate, 0.1 mM Na 2 GTP, 2 mM EGTA, 10 mM HEPES (pH 7.2 with KOH).
Statistical analysis
Data are expressed as mean + SD values. Statistical analysis was performed using the Student's t-test and P , 0.05 was defined as statistically significant.
Results
Functional analysis of conserved non-coding regions within the Hcn4 gene locus
Our previous study revealed that the proximal 847 bp sequence in the Hcn4 upstream region is essential for promoter activity. 9 In order to locate additional cis-regulatory sequences, we extensively searched the CNSs in the genomic locus of Hcn4. As illustrated in Figure 1A , we identified 16 regions using VISTA Enhancer Browser, and designated these regions CNS 1-16 (Supplementary material online, Table S1 ). 8 We next evaluated enhancer activity for each of the CNS regions using the luciferase reporter assay. In order to achieve this, we linked CNS fragments to the Hcn4 promoter expressing the luciferase reporter gene in the pGL4.10 vector ( Figure 1B ) and analysed enhancer function in cultured primary cardiomyocytes. As shown in Figure 1C , nine CNS fragments (CNS1, 2, 3, 4, 6, 8, 11, 13, and 14) significantly enhanced Hcn4 promoter activity. The CNS13 construct led to an 33-fold increase in transcriptional activity, in comparison to the remainder of the constructs that resulted in no more than a 3.2-fold increase.
MEF2 and AP1 sites are required for the enhancer activity of CNS13
To confirm that CNS13 acts as an authentic enhancer, we next constructed inverted CNS13 and tandem repeated CNS13 fragments and fused with the Hcn4 promoter. As shown in Figure 2A , no significant difference was found between the enhancer activities of normal-and inverted-CNS13 fragments. Tandem repeat CNS13 robustly activated the Hcn4 promoter. We then focused our study on the CNS13 sequence and explored its cis-regulatory mechanism and its potential as a novel enhancer for the Hcn4 promoter.
To characterize functional motifs in the CNS13 sequence, we searched putative transcription factor binding sites using the TRANSFAC database and detected MEF2-and AP1-binding motifs. As shown in Figure 2B , the putative MEF2-and AP1-binding sequences are perfectly conserved among several mammalian species and closely resemble their consensus sequences. These motifs, however, were not conserved in non-mammalian species. We prepared CNS13 reporter constructs harbouring mutations within the MEF2 and AP1 sites ( Figure 2C ) and examined whether enhancer activity was mediated by these sites. As shown in Figure 2D , a single mutation in either MEF2-or AP1-binding sequences significantly reduced transcriptional activity, whereas double mutations completely abolished CNS13-induced enhancement. These findings indicate that the cis-enhancer function of the CNS13 fragment is dependent on these binding sequences.
We then examined binding of MEF2 and AP1 protein to CNS13. As demonstrated by the electrophoretic mobility shift assay (EMSA) outlined in Figure 3A , a slow-migrating band was visualized as a result of interaction between the CNS13 probe and the myc-tagged AP1 protein (lane 2). Another complex was also formed when myc-tagged MEF2 protein was co-incubated with the CNS13 probe (lane 4). Myc-antibody also formed additional complexes (lanes 3 and 5). To precisely identify the DNA sequences recognized by MEF2 and AP1 proteins, we performed competitive EMSA using unlabelled competitors composed of partial CNS13 sequences. As shown in Figrue 3B , the signal for the CNS13-AP1 complex was attenuated by the addition of AP1 competitor (lane 4), but not MEF2 competitor (lane 3), indicating that the complex formation is AP1-sequence specific. In CNS13-MEF2 complex competition assays, the opposite patterns were observed ( Figure 3C ). In addition, we amplified a genomic DNA fragment of CNS13 using ChIP with antibodies directed against AP1 and MEF2 ( Figure 3D ). These findings strongly suggest that MEF2 and AP1 transcription factors bind to CNS13 and play an important physiological role in Hcn4 transcription.
dnMEF2 resulted in reduced Hcn4 expression
Among the MEF2 family of transcription factors, MEF2A, C, and D are expressed in cardiomyocytes. 10 Given that AP1 is a ubiquitously expressed transcription factor, we focused our study on the physiological role of MEF2. It has previously been shown that MEF2 proteins form hetero-and homodimers and that overexpression of dnMEF2 inhibit its transcriptional activity. 11 The schematic in Figure 4A outlines the structure of dnMEF2. In the current study, we demonstrate that dnMEF2 significantly reduced the transcriptional activity of the luciferase reporter vectors and that the enhancer activity of CNS13 was attenuated to 12% of the control levels. When MEF2 binding motif of CNS13 was disrupted, the overexpression of dnMEF2 did not significantly inhibit the enhancer activity ( Figure 4B) .
In order to examine the physiological role of MEF2 in vivo, we next expressed dnMEF2 using the AAV1 vector in cardiomyocytes isolated from the inflow tract of the embryonic rat heart, a site in which the HCN4 channel is highly expressed. 12 As shown in Figure 5A , 70% of cardiomyocytes was successfully transfected with dnMEF2. Three days following the transfection, Hcn4 expression levels of Hcn4 were evaluated using real-time PCR. We also evaluated the expression levels of striated muscle activator of Rho signalling (Stars), which is known as a direct transcriptional target of MEF2. 13 As shown in Figure 5A and B, we found that both Stars and Hcn4 mRNA levels were significantly reduced in dnMEF2-transfected myocytes, when compared with GFP-transfected myocytes as the negative control. In dnMEF2-transfected myocytes, however, the mRNA levels of HCN1 and HCN2, other types of HCN channels expressed in the heart, were not changed significantly (Supplementary material online, Figure S1 ). These channels might be regulated by different transcriptional mechanisms. 14 We finally examined the functional expression of the HCN4 channel in embryonic myocytes transfected with dnMEF2. As shown in Figure 6A (left panel), HCN4 protein was clearly identified in control myocytes. However, only faint staining of HCN4 protein was observed in the myocytes transfected with dnMEF2 (nuclear-localized orange signals). In accordance with this, robust I h current was also recorded in the control myocytes ( Figure 6B, upper traces) , whereas I h current was significantly reduced in dnMEF2-transfected myocytes ( Figure 6B, lower traces) . Figure 6C outlines the current-voltage diagram. The amplitude of I h in dnMEF2-transfected myocytes was 18% of the control myocytes. Similar results were also obtained for ES-derived cardiomyocytes (data not shown). 15 
Discussion
The transcription factors AP1 and MEF2 are known to play a variety of roles in the development of the heart. It has been reported that the ablation of c-jun, who along with c-fos forms the AP1 transcription factor, gave rise to the anomalies of right ventricular outflow tract and a reduction in Cx43 expression. 16 Although we did not examine the direct physiological role of AP1 in the present study, it appears reasonable to expect that the expression of the Hcn4 gene might also be reduced following the deletion of the AP1 protein. During development, MEF2C is known to be the predominant form of MEF2 expressed in the embryonic heart. MEF2A and MEF2D became the major MEF2 forms after birth. 10 Gene knockout of MEF2C results in an embryonic lethal phenotype.
17 MEF2D 2/2 mice are viable, demonstrating a weak response to hypertrophic stimulation.
18
MEF2A knockout mice generated on a 129Sv background die immediately following birth and demonstrate sinus arrhythmia and conduction block. 19 As the present study demonstrates that the expression of Hcn4 is dependent on MEF2, it would be interesting to explore the ion channel expression in SAN of MEF2A 2/2 animals. Recent studies have suggested that the Nkx2-5 and Pitx2c transcription factors repress the expression of Hcn4 in chamber myocardium, a result that is likely due to the inhibition of activators. 16 However, activators of Hcn4 have not been identified in cardiomyocytes to date. The results of the current study suggest that MEF2 and AP1 may be candidate activators. The transcription factor Tbx3, in addition to Hcn4, is also specifically expressed in SAN. Ectopic expression of Tbx3 in the atrium is known to induce Hcn4 expression. However, it remains unclear whether Hcn4 is a direct target of Tbx3.
5 Interestingly, we identified conserved MEF2-and AP1-like sequences within the tbx3 gene locus. The spatiotemporal expression of Tbx3 and Hcn4 might be regulated via similar mechanisms.
MEF2 expression in the heart has been shown to be increased in the atrium. 20 Therefore, regional differences in MEF2 expression might account in part for the spatial distribution of Hcn4. In this respect, it appears to be particularly important to investigate whether CNS13 is able to reproduce the spatiotemporal expression pattern of Hcn4 in the heart. Although we have generated transgenic mice harbouring a LacZ reporter gene driven by the CNS13 and Hcn4 promoter, we were unable to obtain consistent patterns of b-gal expression in embryos (data not shown). Thus, it is speculated that a combination of multiple CNSs may be required to reproduce the precise spatiotemporal expression pattern of Hcn4. Future studies will be required to address this question.
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